Ketamine alters oscillatory coupling in the hippocampus

Scientific Reports

Volumn 3, Issue , 2013, Pages

  Caixeta, Fábio V ^a,b   Cornélio, Alianda M ^a   Scheffer Teixeira, Robson ^a   Ribeiro, Sidarta ^a   Tort, Adriano B L ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO NORTE   (Brazil)

^b Edmond and Lily Safra International Institute of Neuroscience of Natal   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

KETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ANIMAL; ANTAGONISTS AND INHIBITORS; BIOLOGICAL RHYTHM; DOSE RESPONSE; DRUG EFFECTS; ELECTROENCEPHALOGRAM; HIPPOCAMPUS; MALE; NERVE CELL NETWORK; NERVE TRACT; PHYSIOLOGY; RAT; WISTAR RAT; ARTICLE; DRUG ANTAGONISM; DRUG EFFECT;

ANIMALS; BIOLOGICAL CLOCKS; BRAIN WAVES; DOSE-RESPONSE RELATIONSHIP, DRUG; HIPPOCAMPUS; KETAMINE; MALE; NERVE NET; NEURAL PATHWAYS; RATS; RATS, WISTAR; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 84881412950     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep02348     Document Type: Article

References (60)

1. Engel, A. K., Fries, P. & Singer, W. Dynamic predictions: oscillations and synchrony in top-down processing. Nat Rev Neurosci 2, 704-716 (2001). (Pubitemid 33674816)
2. Sirota, A. et al. Entrainment of neocortical neurons and gamma oscillations by the hippocampal theta rhythm. Neuron 60, 683-697 (2008).
3. Buzsaki, G. & Draguhn, A. Neuronal oscillations in cortical networks. Science 304, 1926-1929 (2004).
4. Uhlhaas, P. J. & Singer, W. Neural synchrony in brain disorders: relevance for cognitive dysfunctions and pathophysiology. Neuron 52, 155-168 (2006). (Pubitemid 44466360)
5. Uhlhaas, P. J. & Singer, W. Abnormal neural oscillations and synchrony in schizophrenia. Nat Rev Neurosci 11, 100-113 (2010).
6. Spencer, K. M. et al. Neural synchrony indexes disordered perception and cognition in schizophrenia. Proc Natl Acad Sci USA 101, 17288-17293 (2004). (Pubitemid 39627812)
7. Flynn, G. et al. Increased absolute magnitude of gamma synchrony in first-episode psychosis. Schizophr Res 105, 262-271 (2008).
8. Moran, L. V. & Hong, L. E. High vs low frequency neural oscillations in schizophrenia. Schizophr Bull 37, 659-663 (2011).
9. Krystal, J. H. et al. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry 51, 199-214 (1994). (Pubitemid 24081509)
10. Lahti, A. C., Weiler, M. A., Tamara Michaelidis, B. A., Parwani, A. & Tamminga, C. A. Effects of ketamine in normal and schizophrenic volunteers. Neuropsychopharmacology 25, 455-467 (2001). (Pubitemid 32830950)
11. Ma, J. & Leung, L. S.Relation between hippocampal gamma waves and behavioral disturbances induced by phencyclidine and methamphetamine. Behav Brain Res 111, 1-11 (2000). (Pubitemid 30326697)
12. Pinault, D. N-methyl d-aspartate receptor antagonists ketamine and MK-801 induce wake-related aberrant c oscillations in the rat neocortex. Biol Psychiatry 63, 730-735 (2008). (Pubitemid 351400766)
13. Kocsis, B. Differential role of NR2A and NR2B subunits in N-methyl-D-aspartate receptor antagonist-induced aberrant cortical gamma oscillations. Biol Psychiatry 71, 987-995 (2012).
14. Hakami, T. et al. NMDA receptor hypofunction leads to generalized and persistent aberrant gamma oscillations independent of hyperlocomotion and the state of consciousness. PLoS One 4, e6755 (2009).
15. Kittelberger, K., Hur, E. E., Sazegar, S., Keshavan, V. & Kocsis, B. Comparison of the effects of acute and chronic administration of ketamine on hippocampal oscillations: relevance for the NMDA receptor hypofunction model of schizophrenia. Brain Struct Funct 217, 395-409 (2012).
16. Adell, A., Jimenez-Sanchez, L., Lopez-Gil, X. & Romon, T. Is the acute NMDA receptor hypofunction a valid model of schizophrenia? Schizophr Bull 38, 9-14 (2012).
17. Zhang, Y., Yoshida, T., Katz, D. B. & Lisman, J. E. NMDAR antagonist action in thalamus imposes delta oscillations on the hippocampus. J Neurophysiol 107, 3181-3189 (2012).
18. Lazarewicz, M. T. et al. Ketamine modulates theta and gamma oscillations. J Cogn Neurosci 22, 1452-1464 (2010).
19. Hinman, J. R., Penley, S. C., Escabi, M. A. & Chrobak, J. J. Ketamine disrupts theta synchrony across the septotemporal axis of the CA1 region of hippocampus. J Neurophysiol 109, 570-579 (2013).
20. Jensen, O. & Colgin, L. L. Cross-frequency coupling between neuronal oscillations. Trends Cogn Sci 11, 267-269 (2007). (Pubitemid 46962330)
21. Canolty, R. T. & Knight, R. T. The functional role of cross-frequency coupling. Trends Cogn Sci 14, 506-515 (2010).
22. Tort, A. B., Komorowski, R., Eichenbaum, H. & Kopell, N. Measuring phase-amplitude coupling between neuronal oscillations of different frequencies. J Neurosci 104, 1195-1210 (2010).
23. Scheffer-Teixeira, R. et al. Theta phase modulates multiple layer-specific oscillations in the CA1 region. Cereb Cortex 22, 2404-2414 (2012).
24. Tort, A. B. et al. Dynamic cross-frequency couplings of local field potential oscillations in rat striatum and hippocampus during performance of a T-maze task. Proc Natl Acad Sci USA 105, 20517-20522 (2008).
25. Kirihara, K., Rissling, A. J., Swerdlow, N. R., Braff, D. L. & Light, G. A. Hierarchical organization of gamma and theta oscillatory dynamics in schizophrenia. Biol Psychiatry 71, 873-880 (2012).
26. Harrison, P. J. The hippocampus in schizophrenia: a review of the neuropathological evidence and its pathophysiological implications. Psychopharmacology (Berl) 174, 151-162 (2004). (Pubitemid 38925100)
27. Bragin, A. et al. Gamma (40-100 Hz) oscillation in the hippocampus of the behaving rat. J Neurosci 15, 47-60 (1995).
28. Hunt, M. J., Raynaud, B. & Garcia, R. Ketamine dose-dependently induces high-frequency oscillations in the nucleus accumbens in freely moving rats. Biol Psychiatry 60, 1206-1214 (2006). (Pubitemid 44693529)
29. Nicolas, M. J. et al. Ketamine-induced oscillations in the motor circuit of the rat basal ganglia. PLoS One 6, e21814 (2011).
30. Scheffer-Teixeira, R., Belchior, H., Leao, R. N., Ribeiro, S. & Tort, A. B. On high-frequency field oscillations (.100 Hz) and the spectral leakage of spiking activity. J Neurosci 33, 1535-1539 (2013).
31. Scheffzuk, C. et al. Selective coupling between theta phase and neocortical fast gamma oscillations during REM-sleep in mice. PLoS One 6, e28489 (2011).
32. Jones, N. C. et al. Acute administration of typical and atypical antipsychotics reduces EEG gamma power, but only the preclinical compound LY379268 reduces the ketamine-induced rise in gamma power. Int J Neuropsychopharmacol 15, 657-668 (2012).
33. Caplan, J. B. et al. Human theta oscillations related to sensorimotor integration and spatial learning. J Neurosci 23, 4726-4736 (2003). (Pubitemid 36706201)
34. Buzsaki, G. Theta oscillations in the hippocampus. Neuron 33, 325-340 (2002). (Pubitemid 34158839)
35. Light, G. A. et al. Gamma band oscillations reveal neural network cortical coherence dysfunction in schizophrenia patients. Biol Psychiatry 60, 1231-1240 (2006). (Pubitemid 44693537)
36. Lee, S. H. et al. Quantitative EEG and low resolution electromagnetic tomography (LORETA) imaging of patients with persistent auditory hallucinations. Schizophr Res 83, 111-119 (2006).
37. Spencer, K. M. Baseline gamma power during auditory steady-state stimulation in schizophrenia. Front Hum Neurosci 5, 190 (2011).
38. Lisman, J. & Buzsaki, G. A neural coding scheme formed by the combined function of gamma and theta oscillations. Schizophr Bull 34, 974-980 (2008).
39. Tort, A. B., Scheffer-Teixeira, R., Souza, B. C., Draguhn, A. & Brankack, J. Theta-associated high-frequency oscillations (110-160 Hz) in the hippocampus and neocortex. Prog Neurobiol 100, 1-14 (2013).
40. Tort, A. B., Komorowski, R. W., Manns, J. R., Kopell, N. J. & Eichenbaum, H. Theta-gamma coupling increases during the learning of item-context associations. Proc Natl Acad Sci USA 106, 20942-20947 (2009).
41. O'Donnell, P. & Grace, A. A. Dysfunctions in multiple interrelated systems as the neurobiological bases of schizophrenic symptom clusters. Schizophr Bull 24, 267-283 (1998). (Pubitemid 28404985)
42. Gottesmann, C. & Gottesman, I. The neurobiological characteristics of rapid eye movement (REM) sleep are candidate endophenotypes of depression, schizophrenia, mental retardation and dementia. Prog Neurobiol 81, 237-250 (2007). (Pubitemid 46498898)
43. Freud, S. The Interpretation of Dreams (Plain Label Books, 1950).
44. Douglass, A. B., Hays, P., Pazderka, F. & Russell, J. M. Florid refractory schizophrenias that turn out to be treatable variants of HLA-associated narcolepsy. J Nerv Ment Dis 179, 12-17 (1991).
45. Nakazawa, K. et al. GABAergic interneuron origin of schizophrenia pathophysiology. Neuropharmacology 62, 1574-1583 (2012).
46. Korotkova, T., Fuchs, E. C., Ponomarenko, A., von Engelhardt, J. & Monyer, H. NMDA receptor ablation on parvalbumin-positive interneurons impairs hippocampal synchrony, spatial representations, and working memory. Neuron 68, 557-569 (2010).
47. Carlen, M. et al. A critical role for NMDA receptors in parvalbumin interneurons for gamma rhythm induction and behavior. Mol Psychiatry 17, 537-548 (2012).
48. Belforte, J. E. et al. Postnatal NMDA receptor ablation in corticolimbic interneurons confers schizophrenia-like phenotypes. Nat Neurosci 13, 76-83 (2010).
49. Hahn, C. G. et al. Altered neuregulin 1-erbB4 signaling contributes to NMDA receptor hypofunction in schizophrenia. Nat Med 12, 824-828 (2006).
50. Tort, A. B., Rotstein, H. G., Dugladze, T., Gloveli, T. & Kopell, N. J. On the formation of gamma-coherent cell assemblies by oriens lacunosum-moleculare interneurons in the hippocampus. Proc Natl Acad Sci USA 104, 13490-13495 (2007). (Pubitemid 47293972)
51. Neymotin, S. A. et al. Ketamine disrupts theta modulation of gamma in a computer model of hippocampus. J Neurosci 31, 11733-11743 (2011).
52. Leao, R. N. et al. OLM interneurons differentially modulate CA3 and entorhinal inputs to hippocampal CA1 neurons. Nat Neurosci 15, 1524-1530 (2012).
53. Wulff, P. et al. Hippocampal theta rhythm and its coupling with gamma oscillations require fast inhibition onto parvalbumin-positive interneurons. Proc Natl Acad Sci USA 106, 3561-3566 (2009).
54. Vollenweider, F. X. et al. Metabolic hyperfrontality and psychopathology in the ketamine model of psychosis using positron emission tomography (PET) and [18F]fluorodeoxyglucose (FDG). Eur Neuropsychopharmacol 7, 9-24 (1997). (Pubitemid 27139716)
55. Moghaddam, B., Adams, B., Verma, A. & Daly, D. Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex. J Neurosci 17, 2921-2927 (1997). (Pubitemid 27155025)
56. Green, C. J., Knight, J., Precious, S. & Simpkin, S. Ketamine alone and combined with diazepam or xylazine in laboratory animals: a 10 year experience. Lab Anim 15, 163-170 (1981). (Pubitemid 11073500)
57. Cohen, M. L., Chan, S. L., Way, W. L. & Trevor, A. J. Distribution in the brain and metabolism of ketamine in the rat after intravenous administration. Anesthesiology 39, 370-376 (1973).
58. Tort, A. B. et al. A simple webcam-based approach for the measurement ofrodent locomotion and other behavioural parameters. J Neurosci Methods 157, 91-97 (2006). (Pubitemid 44308362)
59. Mitra, P. & Bokil, H. Observed Brain Dynamics (Oxford University Press, USA, 2007).
60. Kramer, M. A., Tort, A. B. & Kopell, N. J. Sharp edge artifacts and spurious coupling in EEG frequency comodulation measures. J Neurosci Methods 170, 352-357 (2008).